Citation 89135

KURODA,M: MIMAKI,Y: YOKOSUKA,A: HASEGAWA,F: SASHIDA,Y:. (2002). CHOLESTANE GLYCOSIDES FROM THE BULBS OF ORNITHOGALUM THYRSOIDES AND THEIR CYTOTOXIC ACTIVITY AGAINST HL-60 LEUKEMIA CELLS.. 65(10)

Citation Details

TitleCHOLESTANE GLYCOSIDES FROM THE BULBS OF ORNITHOGALUM THYRSOIDES AND THEIR CYTOTOXIC ACTIVITY AGAINST HL-60 LEUKEMIA CELLS.
AuthorsKURODA,M: MIMAKI,Y: YOKOSUKA,A: HASEGAWA,F: SASHIDA,Y:
Year2002
Volume65
Issue10

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Ornithogalum thyrsoides (LILIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FOR
NoneNone
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
STRONG ACTIVITY
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
STRONG ACTIVITY
4Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-5-TRIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-5-TRIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
STRONG ACTIVITY
6Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
INACTIVE
8Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-5-TRIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-5-TRIMETHOXY-BENZOYL-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXCHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(3-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:CHOLEST-5-EN-22-ONE,16-BETA-[(ALPHA-L-ARABINOPYRANOSYL)-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY:CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSY(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
STRONG ACTIVITY
10Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-5-TRIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
11Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSYL(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
INACTIVE
13Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
14Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-5-TRIMETHOXY-BENZOYL-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OX
None
15Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-4-HYDROXY-3-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-4-HYDROXY-3-METHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
INACTIVE
17Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLEST-5-EN-22-ONE,3-BETA-[(O-BETA-D-GLUCOPYRANOSYL(1-4)-O-BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(3-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
18Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLEST-5-EN-22-ONE,16-BETA-[(ALPHA-L-ARABINOPYRANOSYL)-3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY]-17-ALPHA-HYDROXY:
None
19Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-BETA-D-XYLOPYRANOSY(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
20Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
None
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLEST-5-EN-22-ONE,3-BETA-[(BETA-D-GLUCOPYRANOSYL)-OXY)]-17-ALPHA-HYDROXY-16-BETA-[(O-(2-O-3-4-DIMETHOXY-BENZOYL-BETA-D-XYLOPYRANOSYL)-(1-3)-2-O-ACETYL-ALPHA-L-ARABINOPYRANOSYL)-OXY]:
STRONG ACTIVITY
Show SPARQL Queries (1)